ARO-HBV

· Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARO-HBV, covering 2024-06-04 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) [Phase 1, Phase 2]